PT4061328T - Comprimidos orodispersíveis de zonisamida - Google Patents
Comprimidos orodispersíveis de zonisamidaInfo
- Publication number
- PT4061328T PT4061328T PT208081174T PT20808117T PT4061328T PT 4061328 T PT4061328 T PT 4061328T PT 208081174 T PT208081174 T PT 208081174T PT 20808117 T PT20808117 T PT 20808117T PT 4061328 T PT4061328 T PT 4061328T
- Authority
- PT
- Portugal
- Prior art keywords
- zonisamide
- orodispersible tablets
- orodispersible
- tablets
- zonisamide orodispersible
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19383034 | 2019-11-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT4061328T true PT4061328T (pt) | 2024-04-08 |
Family
ID=68808236
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT208081174T PT4061328T (pt) | 2019-11-22 | 2020-11-20 | Comprimidos orodispersíveis de zonisamida |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP4061328B1 (https=) |
| JP (1) | JP7650274B2 (https=) |
| ES (1) | ES2976470T3 (https=) |
| PT (1) | PT4061328T (https=) |
| WO (1) | WO2021099531A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024090218A (ja) * | 2022-12-22 | 2024-07-04 | ダイト株式会社 | 崩壊遅延を改善したゾニサミド含有口腔内速崩壊錠 |
| AU2024227385A1 (en) * | 2024-03-28 | 2025-10-16 | Athena Pharmaceutiques Sas | Lisdexamfetamine dimesylate orodispersible tablet and process for preparation thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4989733B2 (ja) | 2008-02-13 | 2012-08-01 | 大日本住友製薬株式会社 | 口腔内崩壊錠 |
| JP5680898B2 (ja) | 2010-08-10 | 2015-03-04 | 京都薬品工業株式会社 | 苦味を抑制した速崩壊錠 |
| JP6230539B2 (ja) | 2012-09-20 | 2017-11-15 | 株式会社ダイセル | 酸型カルボキシメチルセルロース及び結晶セルロースを含む崩壊性粒子組成物及び該組成物を含む口腔内崩壊錠剤 |
| JP6271802B1 (ja) | 2017-09-28 | 2018-01-31 | 武田テバファーマ株式会社 | 口腔内崩壊錠 |
-
2020
- 2020-11-20 WO PCT/EP2020/082809 patent/WO2021099531A1/en not_active Ceased
- 2020-11-20 PT PT208081174T patent/PT4061328T/pt unknown
- 2020-11-20 JP JP2022529813A patent/JP7650274B2/ja active Active
- 2020-11-20 EP EP20808117.4A patent/EP4061328B1/en active Active
- 2020-11-20 ES ES20808117T patent/ES2976470T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP4061328A1 (en) | 2022-09-28 |
| JP7650274B2 (ja) | 2025-03-24 |
| JP2023502738A (ja) | 2023-01-25 |
| ES2976470T3 (es) | 2024-08-01 |
| EP4061328B1 (en) | 2024-01-03 |
| WO2021099531A1 (en) | 2021-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2572126B (en) | Pharmaceutical | |
| GB2569961B (en) | Pharmaceutical | |
| GB2572125B (en) | Pharmaceutical | |
| IL272838A (en) | Peptidase-specific ubiquitin inhibition 30 | |
| ZAA201800548S (en) | Tablets | |
| CA194973S (en) | Package | |
| SG11202104665XA (en) | Improved wafer-like sensor | |
| PL4003293T3 (pl) | Rozwój farmaceutyczny | |
| GB201901989D0 (en) | Pharmaceutical combinations | |
| PT4061328T (pt) | Comprimidos orodispersíveis de zonisamida | |
| GB202107179D0 (en) | Early entry | |
| EP3866770C0 (en) | NEW DOSAGE FORM | |
| GB201817485D0 (en) | Protein tablets | |
| GB201903049D0 (en) | Sensor | |
| GB201902361D0 (en) | Sensor | |
| GB201919172D0 (en) | Sensor | |
| GB201904554D0 (en) | Sensor | |
| GB201902515D0 (en) | Sensor | |
| PH32019001025S1 (en) | Pill | |
| CA189811S (en) | Slidebar | |
| GB2589622B (en) | Sensor | |
| CA187233S (en) | Pacifier | |
| GB2587812B (en) | Sensor | |
| CA191469S (en) | Package | |
| CA207713S (en) | Package |